BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:32 PM
Jul 30, 2007
 |  BC Extra  |  Company News

GPC withdraws Orplatna NDA

GPC Biotech (FSE:GPC; GPCB) withdrew an NDA seeking accelerated approval for Orplatna satraplatin to treat patients with hormone-refractory prostate cancer (HRPC) who have failed prior chemotherapy. The decision was based on the July 24 recommendation by FDA's...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >